Carcinoma, Renal Cell

"Carcinoma, Renal Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Descriptor ID	D002292
MeSH Number(s)	C04.557.470.200.025.390 C04.588.945.947.535.160 C12.758.820.750.160 C12.777.419.473.160 C13.351.937.820.535.160 C13.351.968.419.473.160
Concept/Terms	Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinomas, Renal Cell Renal Cell Carcinomas Adenocarcinoma, Renal Cell Adenocarcinomas, Renal Cell Renal Cell Adenocarcinoma Renal Cell Adenocarcinomas Adenocarcinoma Of Kidney Adenocarcinoma Of Kidneys Kidney, Adenocarcinoma Of Kidneys, Adenocarcinoma Of Renal Cell Cancer Cancer, Renal Cell Cancers, Renal Cell Renal Cell Cancers Adenocarcinoma, Renal Adenocarcinomas, Renal Renal Adenocarcinoma Renal Adenocarcinomas Nephroid Carcinoma Carcinoma, Nephroid Carcinomas, Nephroid Nephroid Carcinomas Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Papillary Renal Cell Carcinoma Papillary Renal Cell Carcinoma Renal Cell Carcinoma, Papillary Chromophil Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Grawitz Tumor Tumor, Grawitz Clear Cell Renal Carcinoma Carcinoma, Hypernephroid Carcinomas, Hypernephroid Hypernephroid Carcinoma Hypernephroid Carcinomas Hypernephroma Hypernephromas Collecting Duct Carcinoma (Kidney) Collecting Duct Carcinoma (Kidney) Carcinoma, Collecting Duct (Kidney) Carcinomas, Collecting Duct (Kidney) Collecting Duct Carcinomas (Kidney) Collecting Duct Carcinoma of the Kidney Renal Collecting Duct Carcinoma Collecting Duct Carcinoma Carcinoma, Collecting Duct Carcinomas, Collecting Duct Collecting Duct Carcinomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Renal Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Renal Cell [C04.557.470.200.025.390]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Urologic Neoplasms [C04.588.945.947]
Kidney Neoplasms [C04.588.945.947.535]
Carcinoma, Renal Cell [C04.588.945.947.535.160]
Male Urogenital Diseases [C12]
Urogenital Neoplasms [C12.758]
Urologic Neoplasms [C12.758.820]
Kidney Neoplasms [C12.758.820.750]
Carcinoma, Renal Cell [C12.758.820.750.160]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Kidney Neoplasms [C12.777.419.473]
Carcinoma, Renal Cell [C12.777.419.473.160]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Neoplasms [C13.351.937]
Urologic Neoplasms [C13.351.937.820]
Kidney Neoplasms [C13.351.937.820.535]
Carcinoma, Renal Cell [C13.351.937.820.535.160]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Kidney Neoplasms [C13.351.968.419.473]
Carcinoma, Renal Cell [C13.351.968.419.473.160]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Renal Cell".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Renal Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Renal Cell" by people in this website by year, and whether "Carcinoma, Renal Cell" was a major or minor topic of these publications.

Bar chart showing 91 publications over 27 distinct years, with a maximum of 6 publications in 2013 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	3	0	3
1998	1	0	1
1999	2	1	3
2000	2	0	2
2001	3	0	3
2002	1	0	1
2003	1	1	2
2004	1	0	1
2005	3	1	4
2007	5	0	5
2008	5	0	5
2009	4	1	5
2010	2	1	3
2011	2	0	2
2012	2	0	2
2013	6	0	6
2014	4	1	5
2015	4	1	5
2016	2	0	2
2017	5	1	6
2018	2	0	2
2019	2	0	2
2020	5	0	5
2021	3	1	4
2022	5	0	5
2023	3	0	3
2024	4	0	4

Below are the most recent publications written about "Carcinoma, Renal Cell" by people in Profiles.

Hrizat AS, Lin R, Eberle-Singh J, O'Neill R, Xia Y, Testa JR, Uzzo R, McCue PA, Yang H, Li L. Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinoma. Pathol Res Pract. 2025 Feb; 266:155774.

View in: PubMed
Iskandar AS, Zarrabi KK, Tester WJ. Renal cell carcinoma: entering the age of biomarkers. Can J Urol. 2024 Aug; 31(4):11921-11930.

View in: PubMed
Ajmal N, Lallas CD, McCue P, Li L. Succinate Dehydrogenase Deficient Renal Cell Carcinoma With Sarcomatoid and Rhabdoid Features-A Diagnostic Dilemma. Int J Surg Pathol. 2024 Dec; 32(8):1508-1513.

View in: PubMed
Pietersen PI, Stougaard S, Keeley FX, Lagerveld B, Breen D, King A, Nielsen TK, van Strijen M, Garnon J, Alcorn D, de Kerviler E, Zondervan P, Wah TM, Junker T, Graumann O. Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary Kidney: An Analysis of European Multinational Prospective EuRECA Registry. Cardiovasc Intervent Radiol. 2024 May; 47(5):583-589.

View in: PubMed
Jirka GW, Lefler DS, Russo J, Bashir B. Colon adenocarcinoma and Birt-Hogg-Dub? syndrome in a young patient: case report and exploration of pathologic implications. Cancer Biol Ther. 2023 12 31; 24(1):2184153.

View in: PubMed
Lin R, Flerova E, Wamsley CE, McCue PA, Lallas CD, Jiang W, Huang J, Wang ZX, Li L. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. Genes Chromosomes Cancer. 2023 06; 62(6):353-360.

View in: PubMed
Ligon JA, Sundby RT, Wedekind MF, Arnaldez FI, Del Rivero J, Wiener L, Srinivasan R, Spencer M, Carbonell A, Lei H, Shern J, Steinberg SM, Figg WD, Peer CJ, Zimmerman S, Moraly J, Xu X, Fox S, Chan K, Barbato MI, Andresson T, Taylor N, Pacak K, Killian JK, Dombi E, Linehan WM, Miettinen M, Piekarz R, Helman LJ, Meltzer P, Widemann B, Glod J. A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. Clin Cancer Res. 2023 01 17; 29(2):341-348.

View in: PubMed
Park HA, Edelmann D, Canzian F, Harrison TA, Hua X, Shi Q, Silverman A, Schneider M, Goldberg RM, Alberts SR, Hoffmeister M, Brenner H, Chan AT, Peters U, Newcomb PA, Chang-Claude J. Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis. Cancer Epidemiol Biomarkers Prev. 2022 11 02; 31(11):2087-2091.

View in: PubMed
Langbein LE, El Hajjar R, He S, Sementino E, Zhong Z, Jiang W, Leiby BE, Li L, Uzzo RG, Testa JR, Yang H. BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma. Cancer Lett. 2022 10 28; 547:215885.

View in: PubMed
Glueck M, Koch A, Brunkhorst R, Ferreiros Bouzas N, Trautmann S, Schaefer L, Pfeilschifter W, Pfeilschifter J, Vutukuri R. The atypical sphingosine 1-phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma. FEBS J. 2022 09; 289(18):5670-5681.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement